396 related articles for article (PubMed ID: 32985256)
1. Glucagon-like peptide-1 alleviates diabetic kidney disease through activation of autophagy by regulating AMP-activated protein kinase-mammalian target of rapamycin pathway.
Yang S; Lin C; Zhuo X; Wang J; Rao S; Xu W; Cheng Y; Yang L
Am J Physiol Endocrinol Metab; 2020 Dec; 319(6):E1019-E1030. PubMed ID: 32985256
[TBL] [Abstract][Full Text] [Related]
2. Renoprotective effect of GLP-1 receptor agonist, liraglutide, in early-phase diabetic kidney disease in spontaneously diabetic Torii fatty rats.
Yamada S; Tanabe J; Ogura Y; Nagai Y; Sugaya T; Ohata K; Natsuki Y; Ichikawa D; Watanabe S; Inoue K; Hoshino S; Kimura K; Shibagaki Y; Kamijo-Ikemori A
Clin Exp Nephrol; 2021 Apr; 25(4):365-375. PubMed ID: 33409761
[TBL] [Abstract][Full Text] [Related]
3. Exogenous supplement of glucagon like peptide-1 protects the heart against aortic banding induced myocardial fibrosis and dysfunction through inhibiting mTOR/p70S6K signaling and promoting autophagy.
Zheng RH; Zhang WW; Ji YN; Bai XJ; Yan CP; Wang J; Bai F; Zhao ZQ
Eur J Pharmacol; 2020 Sep; 883():173318. PubMed ID: 32621911
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of glucagon-like peptide-1 on cardiac remodeling by inhibiting oxidative stress through mammalian target of rapamycin complex 1/p70 ribosomal protein S6 kinase pathway in diabetes mellitus.
Wang D; Jiang L; Feng B; He N; Zhang Y; Ye H
J Diabetes Investig; 2020 Jan; 11(1):39-51. PubMed ID: 31199578
[TBL] [Abstract][Full Text] [Related]
5. Liraglutide ameliorates cognitive decline by promoting autophagy via the AMP-activated protein kinase/mammalian target of rapamycin pathway in a streptozotocin-induced mouse model of diabetes.
Kong FJ; Wu JH; Sun SY; Ma LL; Zhou JQ
Neuropharmacology; 2018 Mar; 131():316-325. PubMed ID: 29305122
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression.
Ojima A; Ishibashi Y; Matsui T; Maeda S; Nishino Y; Takeuchi M; Fukami K; Yamagishi S
Am J Pathol; 2013 Jan; 182(1):132-41. PubMed ID: 23159951
[TBL] [Abstract][Full Text] [Related]
7. Liraglutide relieves myocardial damage by promoting autophagy via AMPK-mTOR signaling pathway in zucker diabetic fatty rat.
Zhang Y; Ling Y; Yang L; Cheng Y; Yang P; Song X; Tang H; Zhong Y; Tang L; He S; Yang S; Chen A; Wang X
Mol Cell Endocrinol; 2017 Jun; 448():98-107. PubMed ID: 28363742
[TBL] [Abstract][Full Text] [Related]
8. Liraglutide promotes autophagy by regulating the AMPK/mTOR pathway in a rat remnant kidney model of chronic renal failure.
Xue L; Pan Z; Yin Q; Zhang P; Zhang J; Qi W
Int Urol Nephrol; 2019 Dec; 51(12):2305-2313. PubMed ID: 31531806
[TBL] [Abstract][Full Text] [Related]
9. Exogenous spermine attenuates diabetic kidney injury in rats by inhibiting AMPK/mTOR signaling pathway.
Zhang X; Zhang L; Chen Z; Li S; Che B; Wang N; Chen J; Xu C; Wei C
Int J Mol Med; 2021 Mar; 47(3):. PubMed ID: 33537831
[TBL] [Abstract][Full Text] [Related]
10. GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway.
He Q; Sha S; Sun L; Zhang J; Dong M
Biochem Biophys Res Commun; 2016 Aug; 476(4):196-203. PubMed ID: 27208776
[TBL] [Abstract][Full Text] [Related]
11. Liraglutide inhibits autophagy and apoptosis induced by high glucose through GLP-1R in renal tubular epithelial cells.
Zhao X; Liu G; Shen H; Gao B; Li X; Fu J; Zhou J; Ji Q
Int J Mol Med; 2015 Mar; 35(3):684-92. PubMed ID: 25573030
[TBL] [Abstract][Full Text] [Related]
12. GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases.
Hendarto H; Inoguchi T; Maeda Y; Ikeda N; Zheng J; Takei R; Yokomizo H; Hirata E; Sonoda N; Takayanagi R
Metabolism; 2012 Oct; 61(10):1422-34. PubMed ID: 22554832
[TBL] [Abstract][Full Text] [Related]
13. GLP-1 Treatment Improves Diabetic Retinopathy by Alleviating Autophagy through GLP-1R-ERK1/2-HDAC6 Signaling Pathway.
Cai X; Li J; Wang M; She M; Tang Y; Li J; Li H; Hui H
Int J Med Sci; 2017; 14(12):1203-1212. PubMed ID: 29104476
[No Abstract] [Full Text] [Related]
14. The human glucagon-like peptide-1 analogue liraglutide regulates pancreatic beta-cell proliferation and apoptosis via an AMPK/mTOR/P70S6K signaling pathway.
Miao XY; Gu ZY; Liu P; Hu Y; Li L; Gong YP; Shu H; Liu Y; Li CL
Peptides; 2013 Jan; 39():71-9. PubMed ID: 23116613
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products-induced inflammation.
Sourris KC; Ding Y; Maxwell SS; Al-Sharea A; Kantharidis P; Mohan M; Rosado CJ; Penfold SA; Haase C; Xu Y; Forbes JM; Crawford S; Ramm G; Harcourt BE; Jandeleit-Dahm K; Advani A; Murphy AJ; Timmermann DB; Karihaloo A; Knudsen LB; El-Osta A; Drucker DJ; Cooper ME; Coughlan MT
Kidney Int; 2024 Jan; 105(1):132-149. PubMed ID: 38069998
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-1 attenuates cardiac hypertrophy via the AngII/AT1R/ACE2 and AMPK/mTOR/p70S6K pathways.
Wang J; Fan S; Xiong Q; Niu Y; Zhang X; Qin J; Shi Y; Zhang L
Acta Biochim Biophys Sin (Shanghai); 2021 Aug; 53(9):1189-1197. PubMed ID: 34357376
[TBL] [Abstract][Full Text] [Related]
17. Exendin-4 alleviates high glucose-induced rat mesangial cell dysfunction through the AMPK pathway.
Xu WW; Guan MP; Zheng ZJ; Gao F; Zeng YM; Qin Y; Xue YM
Cell Physiol Biochem; 2014; 33(2):423-32. PubMed ID: 24556697
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1 attenuates diabetes-associated osteoporosis in ZDF rat, possibly through the RAGE pathway.
Cheng Y; Liu P; Xiang Q; Liang J; Chen H; Zhang H; Yang L
BMC Musculoskelet Disord; 2022 May; 23(1):465. PubMed ID: 35581617
[TBL] [Abstract][Full Text] [Related]
19. Liraglutide protects from renal damage via Akt-mTOR pathway in rats with diabetic kidney disease.
Liao TT; Zhao LB; Liu H; He RL; Wang YQ; Li J
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):117-125. PubMed ID: 31389583
[TBL] [Abstract][Full Text] [Related]
20. The glucagon-like peptide-1 analogue liraglutide promotes autophagy through the modulation of 5'-AMP-activated protein kinase in INS-1 β-cells under high glucose conditions.
Miao X; Gu Z; Liu Y; Jin M; Lu Y; Gong Y; Li L; Li C
Peptides; 2018 Feb; 100():127-139. PubMed ID: 28712893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
